Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Surfolase Capsule vs Surfolase CR
NCT02395913Phase 1Completed
- Sponsor
- Hyundai Pharmaceutical Co., Ltd.
- Start
- Jul 2013
- Primary completion
- Sep 2013
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of acebrophylline in Bronchial hyperreactivity (BHR) (4 arms), sponsored by Hyundai Pharmaceutical Co., Ltd. Primary endpoints: Area Under the Curve to the last measurable concentration and Maximum Concentration. Started Jul 2013; status: completed.
02
Drugs
acebrophylline
03
Conditions
Bronchial hyperreactivity (BHR)
Beyond the preview
Go deeper on NCT02395913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02395913.